SpaceX stock has 38% upside on Wall Street, so why are investors still selling?

Impact · against what's priced in

The article confirms that SpaceX is aggressively scaling its capital expenditure and debt load, reinforcing the market's current refusal to price in bull-case infrastructure targets. While the spectrum acquisition is a strategic win, it adds to the financing risks that the price is already discounting.

NVDA+0.20: Challenges what's priced in
The price assumes: The SpaceX 10-gigawatt partnership generating $120–230 billion in incremental revenue

SpaceX stock has 38% upside on Wall Street, so why are investors still selling?

What matters in this story

Starlink Is Adding 570,000 Subscribers a Month. Here's What That's Worth To SpaceX.

SpaceX stock has 38% upside on Wall Street, so why are investors still selling?

What matters in this story

Starlink Is Adding 570,000 Subscribers a Month. Here's What That's Worth To SpaceX.

How each ticker is affected

Connected tickers

Track these names every morning.

Verizon: Rarely Is Income This Cheap; We Added $1420 Of Income

What To Do As Nokia Shares Trade In A Narrow Range

SpaceX Stock Has Climbed About 50% Through 6 Insider Share Unlocks. The Biggest Is Still Ahead.

Inventiva: Significant Upside Potential Ahead Of Pivotal Liver Disease Readout

SpaceX stock has 38% upside on Wall Street, so why are investors still selling?

What matters in this story

Next reads from the same story arc

Starlink Is Adding 570,000 Subscribers a Month. Here's What That's Worth To SpaceX.

SpaceX stock has 38% upside on Wall Street, so why are investors still selling?

What matters in this story

Next reads from the same story arc

Starlink Is Adding 570,000 Subscribers a Month. Here's What That's Worth To SpaceX.

How each ticker is affected

Connected tickers

Track these names every morning.

Verizon: Rarely Is Income This Cheap; We Added $1420 Of Income

What To Do As Nokia Shares Trade In A Narrow Range

SpaceX Stock Has Climbed About 50% Through 6 Insider Share Unlocks. The Biggest Is Still Ahead.

Inventiva: Significant Upside Potential Ahead Of Pivotal Liver Disease Readout